Phlorizin Ameliorates Glucose and Lipid Metabolism Disorders in T2DM Rats by Modulating IRS-1/PI3K/Akt Signaling Pathway
|更新时间:2026-01-07
|
Phlorizin Ameliorates Glucose and Lipid Metabolism Disorders in T2DM Rats by Modulating IRS-1/PI3K/Akt Signaling Pathway
“The latest research found that phloridzin can effectively improve the disorder of glucose and lipid metabolism in type 2 diabetes rats, and its mechanism may involve IRS-1/PI3K/Akt signaling pathway.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 32, Issue 3, Pages: 139-148(2026)
Aili Nuer,CAO Qingyu,LIU Huan,et al.Phlorizin Ameliorates Glucose and Lipid Metabolism Disorders in T2DM Rats by Modulating IRS-1/PI3K/Akt Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(03):139-148.
Aili Nuer,CAO Qingyu,LIU Huan,et al.Phlorizin Ameliorates Glucose and Lipid Metabolism Disorders in T2DM Rats by Modulating IRS-1/PI3K/Akt Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2026,32(03):139-148. DOI: 10.13422/j.cnki.syfjx.20250644.
Phlorizin Ameliorates Glucose and Lipid Metabolism Disorders in T2DM Rats by Modulating IRS-1/PI3K/Akt Signaling Pathway